Target Health has the expertise and resources to provide for all of your regulatory needs. Our experience and proven track record in the pharmaceutical, biotechnology, and device industries will be invaluable on your path to success.
We have a 100% success rate for market applications such as NDA, BLA, 510(k), de novo, PMA.We have a 100% success rate of prior approval FDA inspections at our Target Health offices.
Experience across review divisions at FDA at all stages of development
Experts at interacting with the FDA on behalf of clients and obtaining high quality feedback, resulting in quicker, more efficient review cyclesProvide guidance to clients from early development stages through post approvalTarget Health collaborates with regulatory bodies to assist in the development of industry guidance and regulatory policy
Take advantage of our experience
Target Health has experience across review divisions at FDA at all stages of development for large and small molecules, as well as cellular therapies and represents clients interacting with FDA to obtain high quality and expeditious review and approval. Additionally, we have expertise in Dietary Supplements, Botanical Drugs, Animal Rule, and Nanoparticles.
Additional capabilities of our Regulatory Group include
Innovation without borders
We partner with you to get your device on a smooth pathway to market. You will benefit from our experience with medical devices and combination products in collaboration with CDRH and CDER Divisions in various therapeutic areas such as cardiovascular, gastroenterology, surgical, dental, neurology, and dermatology, among others.
Biologic, drug, device, or combination? Not clear?
Sometimes the correct path is not the obvious one. Combination products can present a challenging road from development to approval. On your behalf we will lead the way to interact with the Office of Combination Products (OCP) at the FDA to resolve any questions you may have surrounding primary mode of action and the lead center of review at FDA for your product.
As a member of your team, we will
Our Regulatory Operations department is in a class by itself. Backed by tightly honed submission workflows and procedures, our well-versed team of regulatory publishers bring their expertise to whatever submission you need to send through the Electronic Submission Gateway expeditiously and cost-efficiently. We combine rock solid regulatory knowledge and years of experience with drop-dead execution. When it comes to paperless solutions, don’t try to reinvent the wheel. While others struggle to achieve late comer status, Target Health is already an industry leader in eCTD submissions. We have been excelling at electronic submissions for years. Stay ahead of the curve by partnering with Target Health.
We provide
Target Document® is a 21 CFR part 11 compliant, secure, user-friendly, web-based document distribution and management system. The system has the capability to manage users, control versions, share, electronically sign, search, and archive documents, all within a web browser and without installing any software.
Target Health utilizes eCTDXPress exclusively for its eCTD publishing services. eCTDXPress is the quickest and most efficient method of managing an electronic Common Technical Document (eCTD) for regulatory submissions.
TRS Toolbox is an Adobe plug-in with a large set of PDF tools specifically designed for pharmaceutical and biotechnology organizations to use when preparing electronic documents for regulatory submissions.